BTM-1086 is a potent anti-ulcer agent and gastric secretion inhibitor; it demonstrates significant healing effects on acetic acid-induced gastric ulcers; it effectively prevents ulcer development at oral doses of 0.1–1 mg/kg; it markedly inhibits gastric secretion 6 hours after pylorus ligation at a dose of 0.2 mg/kg (i.d.); it dose-dependently prevents aspirin-induced changes in gastric secretion, including reductions in total acid and K⁺, and increases in volume and Na⁺.